GRCE analyst estimates
Grace Therapeutics (GRCE) analyst ratings, the average price target and its range, and every firm's latest call.
- 1 firms rate GRCE: 1 buy, 0 hold, 0 sell.
- The average price target is $4.00 from None analysts, from $4.00 to $4.00.